GTG Wellness Co., Ltd. (KOSDAQ:A219750) announced a private placement of bonds for gross proceeds of KRW 30,000,000,000 on April 20, 2020. The company will issue series 5 non-guaranteed private equity bonds for gross proceeds of KRW 10,000,000,000. The transaction will include participation from Blue Moon Combination. The bonds bear fixed interest rate of 2% per annum, yield to maturity rate of 2%, will mature on June 18, 2023, and are fully convertible into 2,924,831 shares representing 23.75% stake at a fixed conversion price of KRW 3,419 per share from June 19, 2021 till June 18, 2023. The payment date is June 19, 2020. The company will also issue a series 7 unguaranteed private convertible bond for gross proceeds of KRW 10,000,000,000. The transaction will include participation from new investor Greenpeace Fund. The bonds bear coupon rate of 2% and yield to maturity of 2%. The bonds will mature on September 27, 2023. The bonds are 100% convertible into 2,924,831 common shares at a conversion price of KRW 3,419. The start date of conversion period is September 28, 2021 and end date is September 27, 2023. The subscription date is April 20, 2020. The company expects to close the transaction on September 28, 2020. The company will also issue a private placement of series 6 unguaranteed private convertible bond for gross proceeds of KRW 10,000,000,000. The transaction will include participation from new investor Zeus Fund 3. The bonds bear coupon rate of 2% and yield to maturity of 2%. The bonds will mature on August 11, 2023. The bonds are 100% convertible into 2,924,831 common shares at a conversion price of KRW 3,419. The start date of conversion period is August 12, 2021 and end date is August 11, 2023. The subscription date is April 20, 2020. The company expects to close the transaction on August 12, 2020. The transaction has been approved by the company’s board of directors.